JISHA THOMAS: Open Payments
NPI 1255076824 · WEBSTER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,102 in 41 payments from 11 companies in 2025. Trend: 2023 $425 · 2024 $533 · 2025 $1,102
Food & beverage: $1,102
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 6 | $268 |
| Neurocrine BioSciences, Inc. | 9 | $217 |
| Dexcom, Inc. | 8 | $173 |
| Ascendis Pharma Endocrinology Inc | 5 | $129 |
| BETA BIONICS, INC. | 3 | $118 |
| Corcept Therapeutics | 4 | $78 |
| SANOFI-AVENTIS U.S. LLC | 2 | $42 |
| KYOWA KIRIN, INC. | 1 | $23 |
| Ascensia Diabetes Care Us Inc. | 1 | $22 |
| Novo Nordisk Inc | 1 | $17 |
Products named: Omnipod, CRENESSITY, Dexcom G6 Transmitter, Yorvipath, iLet Bionic Pancreas, Korlym, TZIELD, CRYSVITA.
Industry payments across TX — which companies pay providers there.
